Hexagon Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-521
| Closed | -$259K | – | 1572 |
|
|
2025
Q1 | $259K | Sell |
521
-129
| -20% | -$64.2K | 0.05% | 178 |
|
|
2024
Q4 | $338K | Buy |
650
+151
| +30% | +$78.6K | 0.06% | 139 |
|
|
2024
Q3 | $309K | Sell |
499
-14
| -3% | -$8.66K | 0.06% | 150 |
|
|
2024
Q2 | $284K | Buy |
513
+3
| +0.6% | +$1.66K | 0.06% | 154 |
|
|
2024
Q1 | $296K | Sell |
510
-45
| -8% | -$26.2K | 0.07% | 149 |
|
|
2023
Q4 | $295K | Buy |
555
+6
| +1% | +$3.19K | 0.07% | 143 |
|
|
2023
Q3 | $278K | Sell |
549
-9
| -2% | -$4.56K | 0.07% | 128 |
|
|
2023
Q2 | $291K | Sell |
558
-34
| -6% | -$17.7K | 0.08% | 124 |
|
|
2023
Q1 | $341K | Sell |
592
-1
| -0.2% | -$576 | 0.1% | 105 |
|
|
2022
Q4 | $327K | Sell |
593
-111
| -16% | -$61.1K | 0.1% | 107 |
|
|
2022
Q3 | $357K | Sell |
704
-42
| -6% | -$21.3K | 0.11% | 101 |
|
|
2022
Q2 | $405K | Buy |
746
+91
| +14% | +$49.4K | 0.12% | 101 |
|
|
2022
Q1 | $387K | Sell |
655
-12
| -2% | -$7.09K | 0.1% | 115 |
|
|
2021
Q4 | $445K | Sell |
667
-22
| -3% | -$14.7K | 0.12% | 100 |
|
|
2021
Q3 | $394K | Sell |
689
-29
| -4% | -$16.6K | 0.11% | 97 |
|
|
2021
Q2 | $362K | Sell |
718
-46
| -6% | -$23.2K | 0.1% | 102 |
|
|
2021
Q1 | $348K | Sell |
764
-263
| -26% | -$120K | 0.1% | 96 |
|
|
2020
Q4 | $478K | Buy |
1,027
+68
| +7% | +$31.6K | 0.14% | 65 |
|
|
2020
Q3 | $460K | Buy |
+959
| New | +$460K | 0.15% | 66 |
|